Abstract
The present invention provides novel biomarkers of chronic lymphocytic leukemia (CLL). Specifically, the present invention provides methods and kits for diagnosing, assessing the level of severity, and treating of CLL.
| Original language | English |
|---|---|
| Patent number | US2020270701 |
| IPC | G01N 33/ 49 A I |
| Priority date | 19/12/16 |
| State | Published - 27 Aug 2020 |
